1. Impact of urate-lowering therapy on the course of chronic kidney disease in patients with asymptomatic hyperuricemia: a meta-analysis of randomized controlled trials
   Vadim I. Mazurov et al, 2024, HERALD of North-Western State Medical University named after I.I. Mechnikov CrossRef
2. Is Renoprotection Real for Patients with Hyperuricemia?
   Людмила Хіміон et al, 2022, Family medicine CrossRef
3. POSSIBILITIES OF RENOPROTECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERURICEMIA
   Liudmyla V. Khimion et al, 2022, Wiadomości Lekarskie CrossRef
4. Renoprotective and in silico Modeling Studies of Febuxostat in Gentamicin Induced Nephrotoxic Rats
   Ali Alqahtani et al, 2022, International Journal of Pharmacology CrossRef
5. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review
   Anna M. Hu et al, 2020, Clinical Rheumatology CrossRef
6. The place of febuxostat in the treatment of gout
   A. M. Novikova et al, 2020, Modern Rheumatology Journal CrossRef
7. Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
   Xiuping Liang et al, 2022, Frontiers in Pharmacology CrossRef
8. The Hong Kong Society of Rheumatology consensus recommendations for the management of gout
   Ronald ML Yip et al, 2023, Clinical Rheumatology CrossRef